Jefferies raises Constellation Brands target to $201, maintains hold

Published 07/04/2025, 10:58
Jefferies raises Constellation Brands target to $201, maintains hold

On Monday, Jefferies updated its outlook on Constellation Brands (NYSE:STZ) stock, increasing the price target to $201 from the previous $197 while keeping a Hold rating on the shares. The revision follows the anticipation of a challenging first quarter for the company, influenced by various market pressures.

Constellation Brands, known for its portfolio of beer, wine, and spirits, is expected to face headwinds in the upcoming quarter. Analysts at Jefferies predict that subdued demand, retail destocking, and rising inflation expectations will likely result in the company missing its first-quarter financial targets and revising its guidance downwards.

The firm also highlighted the emergence of tariffs as a new obstacle for Constellation Brands to navigate throughout the year. Despite the already low expectations, Jefferies suggests that the bar has been set even lower due to these factors.

The report expressed concerns over the full-year numbers for the Home and Personal Care (HPC) and Beverages Alcohol (Bev Alc) segments. The analysts indicated that it remains uncertain whether the slowdown in these areas is temporary or if it could extend over a longer period.

Jefferies concluded by stating a preference for Soft Drinks and Consumer Health sectors over HPC and Bev Alc, citing more stable trends in the former categories. This strategic stance reflects a cautious approach to the segments that are currently facing more significant challenges.

In other recent news, Celsius Holdings (NASDAQ:CELH) has completed its acquisition of Alani Nutrition for $1.8 billion, netting $1.65 billion after accounting for tax assets. This strategic move is expected to enhance Celsius’s growth in the energy drink sector, particularly appealing to health-conscious consumers. Truist Securities has upgraded Celsius Holdings from Hold to Buy, raising the price target from $35 to $45, citing the long-term benefits of the Alani Nu acquisition. The acquisition is anticipated to strengthen Celsius’s position in the women’s segment of the US energy drink category. Meanwhile, Morgan Stanley (NYSE:MS) has maintained an Equalweight rating on Celsius with a price target of $42, noting a slight improvement in recent sales data. The combined market share of Celsius and Alani Nu has increased, although concerns remain regarding weak retail sales and potential consumer overlap. Despite these challenges, the acquisition is seen as a strategic move to bolster market share and drive future growth. These developments reflect the company’s ongoing efforts to expand its functional beverage portfolio and capture a larger market share.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.